| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |